WO2026120517 - METHODS AND SYSTEMS OF MASS SPECTROMETRY ANALYSIS FOR PRECISION MEDICINE
National phase entry is expected:
Publication Number
WO/2026/120517
Publication Date
11.06.2026
International Application No.
PCT/IB2025/062396
International Filing Date
03.12.2025
Title **
[English]
METHODS AND SYSTEMS OF MASS SPECTROMETRY ANALYSIS FOR PRECISION MEDICINE
[French]
PROCÉDÉS ET SYSTÈMES D'ANALYSE PAR SPECTROMÉTRIE DE MASSE POUR MÉDICAMENT DE PRÉCISION
Applicants **
PREVIEW HEALTH PTY LTD
Inventors
ZHANG, Jiahui Diana
DONALD, William Alexander
DUTTA, Rishi
LIU, Yize
NG, Dominick
Priority Data
63/727,907
04.12.2024
US
63/800,906
06.05.2025
US
63/880,830
12.09.2025
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4797 | |
| EPO | Filing, Examination, Granting | 79411 | |
| Japan | Filing, Examination, Granting | 4406 | |
| South Korea | Filing, Examination, Granting | 7030 | |
| USA | Filing, Examination, Granting | 19540 |
Total:
115,184
Contact Us
Abstract[English]
Described herein is a method of processing and analyzing mass spectrometry data in its original state with minimal to no data reduction for analysis directly by a machine learning classifier. This may be for the purposes of diagnosing, detecting, classifying, predicting, stratifying, screening or monitoring one or more medical conditions or disease states, and discovering biomarker signatures.[French]
L'invention concerne un procédé de traitement et d'analyse de données de spectrométrie de masse dans leur état d'origine avec une réduction de données minimale ou nulle pour une analyse directement par un classificateur à apprentissage automatique. Cela peut être à des fins de diagnostic, de détection, de classification, de prédiction, de stratification, de criblage ou de surveillance d'une ou de plusieurs affections médicales ou d'un ou de plusieurs états pathologiques et de découverte de signatures de biomarqueurs.